Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum

JAMA Dermatol. 2023 Feb 1;159(2):226-227. doi: 10.1001/jamadermatol.2022.5261.

Authors

Juliana Kim¹, Stephanie A Savory¹, Shadmehr Demehri², Jennifer G Gill¹

Affiliations

¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas.
² Department of Dermatology, Massachusetts General Hospital, Boston.

PMID: 36542363
DOI: 10.1001/jamadermatol.2022.5261

No abstract available

Plain language summary

This case report describes treatment regimens with topical calcipotriol plus fluorouracil for 2 patients with xeroderma pigmentosum.

MeSH terms

Calcitriol
Fluorouracil
Humans
Skin Neoplasms* / drug therapy
Skin Neoplasms* / prevention & control
Xeroderma Pigmentosum* / complications
Xeroderma Pigmentosum* / drug therapy

Substances

calcipotriene
Fluorouracil
Calcitriol